Abeona Therapeutics Inc. appointed CEO F. Carsten Thiel to be a director on its board.

Thiel, who was appointed CEO in March, replaces Timothy Miller who will continue to serve as the company's chief scientific officer and president.

The Dallas-based clinical-stage biopharmaceutical company also appointed Stefano Buono and Richard Van Duyne to the board.